Pacific Biosciences of California, Inc. (PACB) News

Pacific Biosciences of California, Inc. (PACB): $1.65

0.03 (-1.50%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Filter PACB News Items

PACB News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

PACB News Highlights

  • For PACB, its 30 day story count is now at 9.
  • Over the past 21 days, the trend for PACB's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
  • The most mentioned tickers in articles about PACB are CVRX, GENE and ROKU.

Latest PACB News From Around the Web

Below are the latest news stories about PACIFIC BIOSCIENCES OF CALIFORNIA INC that investors may wish to consider to help them evaluate PACB as an investment opportunity.

PacBio to Present at 42nd Annual J.P. Morgan Healthcare Conference

PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be presenting at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024, at 1:30 PM PT (4:30 PM ET) in San Francisco, California.

Yahoo | December 27, 2023

CVRx (CVRX) Moves 24.2% Higher: Will This Strength Last?

CVRx (CVRX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Yahoo | December 27, 2023

Reasons to Retain PacBio (PACB) Stock in Your Portfolio Now

PacBio's (PACB) product development activities raise optimism about the stock.

Yahoo | December 26, 2023

12 Most Promising Gene Editing Stocks According to Hedge Funds

In this piece, we will take a look at the 12 most promising gene editing stocks according to hedge funds. If you want to skip our take on how the gene editing industry sits right at the top of the global innovation food chain, then you can take a look at the 5 Most Promising […]

Yahoo | December 20, 2023

Investors in Pacific Biosciences of California (NASDAQ:PACB) have unfortunately lost 60% over the last three years

Pacific Biosciences of California, Inc. ( NASDAQ:PACB ) shareholders should be happy to see the share price up 29% in...

Yahoo | December 12, 2023

PacBio Announces the Retirement of David Botstein, Ph.D., from its Board of Directors

PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that David Botstein, Ph.D., a member of PacBio's Board of Directors, has retired from his position effective December 7, 2023.

Yahoo | December 11, 2023

The 3 Best Cathie Wood Stocks to Buy in December

Cathie Wood stocks had a great November and are well-positioned to keep performing well, given the favorable macro backdrop.

Larry Ramer on InvestorPlace | December 10, 2023

12 Best Genomics Stocks To Buy Now

In this piece, we will take a look at the 12 best genomics stocks to buy now. If you want to skip our introduction to the genomics industry and all the latest trends, then take a look at 5 Best Genomics Stocks To Buy Now. If there’s one thing that can be said with certainty […]

Yahoo | December 10, 2023

Shockwave Medical (SWAV) Down 1% Since Last Earnings Report: Can It Rebound?

Shockwave Medical (SWAV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | December 6, 2023

Why Is IQVIA (IQV) Up 12.4% Since Last Earnings Report?

IQVIA (IQV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | December 1, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!